111In-ch806
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 111In-ch806, covering 2021-06-08 to 2021-06-08. Get the full timeline:
Most recent: Clinical Trial Update: 111In-ch806 in Patients With Advanced Tumours Expressing the 806 Antigen [Phase 1]